NEW YORK--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), ...
Gene transfer research is a rapidly advancing field that involves the introduction of a genetic sequence into a human subject for research or diagnostic purposes. Clinical gene transfer trials are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results